TAYLOR ANDREW LAWRENCE (Chief Financial Officer) purchased 0.4% of their position (2K shares) of ORCHESTRA BIOMED HOLDINGS, INC. on the open market
Open‑market purchase worth $5.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/25/2025ACC: 0001104659-25-082633
Officer· Chief Financial Officer
Since Feb 2026
+2K
Net shares
Net buyer
$5.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+2K
Price / share
$2.55
Trade value
$5.10K
% of position
0.4%
8/25/2025
480.79K→482.79K
Total
Net shares
+2K
Net value
$5.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 8/25/2025 | P · Purchase | +2K | $2.55 | $5.10K | 0.4% | 480.79K | 482.79K |
| Total | +2K | $5.10K | ||||||
Derivative Transactions0
No derivative transactions reported